SL
BIOA

Siren LLC’s BioAge Labs BIOA Stock Holding History

Siren LLC’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-382,406
Closed -$2.25M – 138
2025
Q3 		$2.25M Hold
382,406
– – 0.09% 87
2025
Q2 		$1.58M Hold
382,406
– – 0.08% 88
2025
Q1 		$1.44M Sell
382,406
-5,594
-1% -$25.9K 0.08% 91
2024
Q4 		$2.25M Buy
388,000
+88,000
+29% +$1.52M 0.1% 88
2024
Q3 		$6.24M Buy
+300,000
New +$6.01M 0.31% 60

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Siren LLC's BIOA Position: Q4 2025 in Review

Siren LLC sold out of BioAge Labs (BIOA) in Q4 2025, closing a stake of 382,406 shares — an estimated $2.25M sold.

Siren LLC first reported a position in BIOA in Q3 2024 and held it in 5 quarters. The position peaked at $6.24M in Q3 2024. 114 funds tracked by Wall St. Rank hold BIOA as of Q4 2025.

  • Siren LLC reported no remaining BioAge Labs position as of Q4 2025 after selling out during the quarter.
  • Siren LLC sold 382,406 BioAge Labs shares in Q4 2025, an estimated $2.25M.
  • Siren LLC first reported a position in BioAge Labs in Q3 2024 and held it in 5 quarters.
  • Siren LLC's BioAge Labs position peaked at $6.24M in Q3 2024.
  • 114 funds tracked by Wall St. Rank held BioAge Labs as of Q4 2025.

Based on Siren LLC's 13F filing for Q4 2025, filed 13 Feb 2026.